Showing results (481-490 of 490) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 490 results.
Pulmonology|February 16, 2023
Alpha1-antitrypsin deficiency in Greece: Focus on rare variantsS A Papiris, M Veith, A I Papaioannou, et al.
Revue Des Maladies Respiratoires|November 13, 2022
[Updated indications and contraindications in 2022 for lung transplantation in France]J Le Pavec, C Pison, S Hirschi, et al.
ESMO Open|April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trialE de Guillebon, M Jimenez, L Mazzarella, et al.
Clinical Lung Cancer|August 12, 2025
AFSOS-SFRO Guidelines on Radiation-Induced Lung InjuryO Cravereau, V Bourbonne, L Vaugier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2023
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 studyA Passaro, J Wang, Y Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2018
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference CenterF Galateau Salle, N Le Stang, A G Nicholson, et al.
ESMO Open|June 15, 2024
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics projectÉ Mathian, Y Drouet, A Sexton-Oates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2024
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSAE Felip, B C Cho, V Gutiérrez, et al.
Journal of Cardiac Surgery|June 12, 2021
Cardiac surgeons' concerns, perceptions, and responses during the COVID-19 pandemicJessica G Y Luc, Niv Ad, Tom C Nguyen, et al.
Nature Communications|August 22, 2019
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoidsN Alcala, N Leblay, A A G Gabriel, et al.
Pageof 49